In this fifth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC ...
An analysis estimates Trump increased his stock holdings from $1.7 million in 2024 to up to $56.2 million last year.
Page 5th Edition Tracks 46 Recent CDx Approvals and Partnerships, With AI Impact Analysis and Forecasts by Application, Technology, Funding Source and CountryDublin, Oct. (GLOBE NEWSWIRE) -- ...
Capitalize on precision medicine, strategic collaborations, digital biology, computational discovery and multimodal data integration to strengthen market position.Dublin, Oct. (GLOBE NEWSWIRE) -- ...
Study: Patient, consumer reps at FDA adcomms increasingly hold ties to pharma-backed advocacy groups
At some advisory committee meetings, more than half of patient and consumer representatives who attended had connections to ...
Crescent Bioresearch has published findings from its examination of the pass/fail metric on endotoxin certificates and the numerical endotoxin value they omit.
A five-year analysis of more than 36,000 Japanese outpatients shows that the risk factors driving leftover medications shift ...
Mycology reveals fungi's potential in mycoremediation, sustainable construction, and psilocybin research, addressing key ...
Autonomous Mobile Robots Market growth is driven by labor shortages, e-commerce automation demand, and vision-based ...
GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michigan iv ...
Imagine walking into your favourite local chop bar or open-air eatery. The rich aroma of light soup, palm nut soup, or ...
Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results